Restaurant Brands Asia Limited

NSE: RBA

43

total announcements

RBA.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 16 Oct 2026

Market Cap

₹6,527 Cr

P/E (Forward)

572.8

EPS (TTM)

₹-2.94

52W Low

₹57.15

52W High

₹111.15

Dividend Yield

0.00%

Beta

0.42

Price / Book

7.4

Debt / Equity

285.7

Revenue (TTM)

₹2,948 Cr

Gross Margin

47.68%

Operating Margin

-0.40%

NSETrading Window26 Jun 2026

Restaurant Brands Asia Limited

Trading Window

Restaurant Brands Asia Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
NSEAllotment of Securities22 Jun 2026

Restaurant Brands Asia Limited

Allotment of Securities

Restaurant Brands Asia Limited has announced the allotment of 2,71,147 fully paid-up equity shares with a face value of Rs. 10 each. These shares were issued to eligible employees upon the exercise of stock options under the B K Employee Stock Option Scheme, 2015 (1,41,147 shares) and the RBAL Employee Stock Option Scheme – 2024 (1,30,000 shares). This action, approved by the Nomination and Remuneration Committee, increases the company's issued and paid-up equity share capital from 71,14,47,715 shares to 71,17,18,862 shares. The newly allotted shares will rank pari-passu with the existing equity shares.

Read more →📎 1 attachment
NSEUpdates▲ PositiveExpansion22 Jun 2026

Restaurant Brands Asia Limited

Updates

Restaurant Brands Asia Limited has completed the subscription of 35,000 redeemable cumulative non-convertible preference shares in its Indonesian subsidiary, PT Sari Burger Indonesia. This investment totals IDR 35 billion (approximately INR equivalent) and follows a prior intimation on April 24, 2026. This capital infusion is intended to support the operational and growth initiatives of the Indonesian subsidiary.

Read more →📎 1 attachment
← PreviousPage 3 of 3